Change Financial Ltd trends down on June Quarter 2018 report


Expects New Phase of Growth: Change Financial Ltd.’s (ASX: CCA) stock continues to fall further by 7.7% on August 2, 2018 after the company released the report for the June quarter 2018 and expects new phase of growth. During the June quarter 2018, CCA has appointed leadership and raised funds for the strategic acquisition of the Ivy Entities (‘Ivy’). The company has appointed Eric Bachman as CEO effective from 1 August 2018 as part of restructuring the company. CCA has  raised US$2.62 million in a heavily oversubscribed placement to fund working capital, acquisition of the Ivy call-option (US$250,000) and deployment of enterprise solution.

[optin-monster-shortcode id=”wxhmli4jjedneglg1trq”]

The acquisition of Ivy Entities is subject to shareholder approval. The company has planned to integrate the Ivy platform into its enterprise solution and consumer product to evolve its unified payments platform. Further, Ivy during the quarter has signed a partnership with HiveEx, which is a leading cryptocurrency trading platform, to launch IvyPay, a platform that is expected to turn cryptocurrency into AUD instantly and allow it to be used to make payments. Moreover, CCA has finalised connectivity testing with Mastercard of innovative Software-as-a-Service enterprise solution and progressing closer for a  commercial launch. Additionally, CCA has achieved the 40% growth in the total transaction volume of US$35 million, deposits of US$11.9 million and record efficiency of cost of acquiring customers of just US$10 per customer in the company’s consumer product. At the end of the June quarter, the company has cash of $1.67 million. Meanwhile, CCA stock has fallen 54.95% in three months as on August 01, 2018.

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Checkout our Free Dividend Stocks Report

Specially made for income-hungry investors, Invest in growing Franked Dividends an opportunity that should not be missed.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report